Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Esperion Therapeutics Inc...

    NASDAQ: ESPR · Real-Time Price · USD
    2.15
    0.08 (3.86%)
    At close: Aug 15, 2025, 9:56 AM

    Esperion Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -51.74M -209.25M -233.66M -269.11M
    Depreciation & Amortization
    		 63K 164K 500K 612K
    Stock-Based Compensation
    		 11.99M 11.96M 15.21M 24.31M
    Other Working Capital
    		 -12.45M 50.18M 2.63M 10.39M
    Other Non-Cash Items
    		 76.56M 47.96M 46.49M 35.53M
    Deferred Income Tax
    		 n/a n/a n/a -2.63M
    Change in Working Capital
    		 -60.53M 13.68M -3.37M -52.51M
    Operating Cash Flow
    		 -23.65M -135.49M -174.83M -263.81M
    Capital Expenditures
    		 -317K n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -59.9M -50.48M
    Sales Maturities Of Investments
    		 n/a 42.5M 68M n/a
    Other Investing Acitivies
    		 n/a n/a 8.1M -50.48M
    Investing Cash Flow
    		 -317K 42.5M 8.1M -50.48M
    Debt Repayment
    		 35.01M n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -39.72M -6.42M -58.24M 49.53M
    Financial Cash Flow
    		 86.48M 50.46M 32.61M 268.22M
    Net Cash Flow
    		 62.51M -42.53M -134.12M -46.07M
    Free Cash Flow
    		 -23.97M -135.49M -174.83M -263.81M

    Add to Watchlist